Edward J. Dulac III, Chief Financial Officer at FATE THERAPEUTICS INC (FATE), sold 7,331 shares at $5.24 ($38K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Open-market sale of $38k FATE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2026-01-07 | $59K | — | Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |